Literature DB >> 16358148

[Heart failure mortality trend in Salvador, Bahia, Brazil].

Adriana Lopes Latado1, Luiz Carlos Santana Passos, Rodrigo Guedes, Alessandra B Santos, Marianna Andrade, Simone Moura.   

Abstract

OBJECTIVE: To assess mortality trend due to heart failure (HF) in Salvador--Bahia, from 1979 to 1995.
METHODS: HF was defined by notations from the 9th Review of International Disease Code (IDC9) 428.0, 428.1 and 428.9. HF death and population data (metropolitan area of Salvador) were obtained by means of Secretaria de Saúde da Bahia (Bahia State Health Secretariat) and Instituto Brasileiro de Geografia e Estatística (Brazilian Institute of Geography and Statistics). Mortality rates (/100,000) were total or per gender and age, and gross or adapted per age (straight standardization).
RESULTS: Mortality rates due to HF had a progressive reduction in the period of time assessed, for both genders, especially up to 1992. From then and up to 1995, there was an apparent stabilization of the curves. Gross mortality rate went from 25.0/10(5), in 1979, to 16.4/10(5) inhabitants, in 1995 (a decrease of 34.4%). The reduction was 34.0% (23.3/10(5), in 1979, to 15.4/10(5) inhabitants, in 1995) for male sex and 35.2% (26.7/10(5), in 1979, to 17.3/10(5) inhabitants, in 1995), for female sex. The same trend took place in several age ranges, including the population > or = 40 years old, which has a greater risk for HF. After adaptation per age (standard population of 1979), it is observed that relative reductions in the rates were even greater.
CONCLUSION: Mortality due to HF, in Salvador-Bahia, decreased from 1979 to 1992, becoming stable from then to 1995.

Entities:  

Mesh:

Year:  2005        PMID: 16358148     DOI: 10.1590/s0066-782x2005001800005

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  1 in total

1.  Mortality by heart failure and ischemic heart disease in Brazil from 1996 to 2011.

Authors:  Eduardo Nagib Gaui; Gláucia Maria Moraes de Oliveira; Carlos Henrique Klein
Journal:  Arq Bras Cardiol       Date:  2014-06       Impact factor: 2.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.